PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
<h4>Background</h4> Immune checkpoint inhibition is effective in several cancers. Expression of programmed death-ligand 1 (PD-L1) on circulating tumor or immune effector cells could provide insights into selection of patients for immune checkpoint inhibition. <h4>Methods</h4>...
Guardado en:
Autores principales: | Elizabeth P. Darga, Emily M. Dolce, Fang Fang, Kelley M. Kidwell, Christina L. Gersch, Steven Kregel, Dafydd G. Thomas, Anoop Gill, Martha E. Brown, Steven Gross, Mark Connelly, Michael Holinstat, Erin F. Cobain, James M. Rae, Daniel F. Hayes, Costanza Paoletti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63089b9215d1428799266b1d9644f894 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
por: Elizabeth P Darga, et al.
Publicado: (2021) -
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Costanza Paoletti, et al.
Publicado: (2021) -
Assessment of growth factors with three different platelet preparations, namely platelet-rich fibrin, platelet-rich plasma, and lyophilized platelet: An In vitro study
por: R Hariprasad, et al.
Publicado: (2021) -
The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021) -
Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p
por: Mingyi Qu, et al.
Publicado: (2020)